Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Share News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 267.50
Bid: 267.00
Ask: 270.00
Change: 12.00 (4.70%)
Spread: 3.00 (1.124%)
Open: 255.50
High: 268.00
Low: 251.00
Prev. Close: 255.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Synthomer annual loss widens but on-track for longer-term growth

Tue, 12th Mar 2024 10:58

(Alliance News) - Synthomer PLC on Tuesday said is loss widened in 2023 as revenue dropped, but said it has been taking "decisive actions" for longer term growth.

Shares in Synthomer jumped 33% to 190.36 pence each in London on Tuesday morning.

The Essex, England-based chemicals manufacturer said revenue fell 15% to GBP1.97 billion in 2023 from GBP2.33 billion the year before, due to a reduction in volume and pass through of lower raw material input prices, the firm explained.

Pretax loss widened significantly to GBP106.8 million from GBP34.2 million as a result.

Further, the firm swung to an underlying pretax loss of GBP27.2 million from a GBP123.7 million underlying pretax profit in 2022.

Looking ahead, Synthomer said trading since the start of 2024 has been "cautiously encouraging", due to short-term restocking by customers. "We remain confident that Synthomer's medium-term earnings power is more than double recent levels, through a combination of our near-term actions, end market volume recovery and strategic delivery," it added.

Commenting on the firm's results, Chief Executive Officer Michael Willome said: "Despite a challenging year, we have taken decisive actions to position the business well for the future. We remain focused on enhancing our strong positions in key end-markets, optimising our portfolio and cost position, and demonstrating the cash generative nature of our business. In the medium term, we remain confident that Synthomer's earnings power is more than double recent levels, through a combination of our near-term self-help actions, end market recovery and delivery of our speciality solutions strategy."

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
23 Apr 2021 09:35

BROKER RATINGS: Barclays doubles downgrades Workspace to underweight

BROKER RATINGS: Barclays doubles downgrades Workspace to underweight

Read more
22 Apr 2021 16:10

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
22 Apr 2021 16:09

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
22 Apr 2021 09:41

BROKER RATINGS: JPMorgan cuts Synthomer to neutral from overweight

BROKER RATINGS: JPMorgan cuts Synthomer to neutral from overweight

Read more
22 Apr 2021 08:09

LONDON BRIEFING: Informa hoping for return of physical events

LONDON BRIEFING: Informa hoping for return of physical events

Read more
21 Apr 2021 10:16

Synthomer has "stronger" trading in first quarter across all divisions

Synthomer has "stronger" trading in first quarter across all divisions

Read more
21 Apr 2021 09:42

BROKER RATINGS: Deutsche Bank starts coverage on BP and Shell at buy

BROKER RATINGS: Deutsche Bank starts coverage on BP and Shell at buy

Read more
21 Apr 2021 08:09

Synthomer ups full-year earnings guidance, shares spark

(Sharecast News) - Synthomer has upped its 2021 earnings guidance following a strong start to 2021, sending shares in the FTSE 250 chemicals specialist higher.

Read more
14 Apr 2021 09:38

BROKER RATINGS: UBS says buy FirstGroup, National Express, Stagecoach

BROKER RATINGS: UBS says buy FirstGroup, National Express, Stagecoach

Read more
31 Mar 2021 16:49

Director dealings: Synthomer CEO ups stake

(Sharecast News) - Synthomer said on Wednesday that chief executive Callum MacLean had acquired 31,979 ordinary shares in the FTSE 250-listed chemicals group.

Read more
19 Mar 2021 15:51

DIRECTOR DEALINGS: Wizz Air Chair William Franke cuts stake to 57.6%

DIRECTOR DEALINGS: Wizz Air Chair William Franke cuts stake to 57.6%

Read more
9 Mar 2021 09:56

BROKER RATINGS: SocGen downgrades Pearson to Hold from Buy

BROKER RATINGS: SocGen downgrades Pearson to Hold from Buy

Read more
8 Mar 2021 09:41

BROKER RATINGS: Unilever, Aggreko upgraded and Virgin Money UK cut

BROKER RATINGS: Unilever, Aggreko upgraded and Virgin Money UK cut

Read more
8 Mar 2021 08:23

LONDON BRIEFING: ii buys share trading platform from Equiniti

LONDON BRIEFING: ii buys share trading platform from Equiniti

Read more
5 Mar 2021 13:07

Friday broker round-up

(Sharecast News) - Aggreko: Peel Hunt upgrades to hold with a target price of 880p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.